Newtyn Management, LLC
About Newtyn Management, LLC’s 13F portfolio
Newtyn Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Newtyn Management, LLC reported $800.9M across 34 US-listed positions (). Its largest position is QUIDELORTHO CORP (QDEL) at 14% of the reported book, and its ten biggest holdings make up 62% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: QDEL QUIDELORTHO CORP | $9.57 −3.04% | 14% | 6.6M | $116.0M |
| 2 | NASDAQ: TBPH THERAVANCE BIOPHARMA INC | $17.03 0.00% | 7.3% | 3.4M | $58.4M |
| 3 | NASDAQ: INDV INDIVIOR PHARMACEUTICALS INC | $26.74 −5.21% | 6.7% | 1.3M | $53.6M |
| 4 | NYSE: CNNE CANNAE HLDGS INC | $17.50 +2.64% | 5.7% | 3.2M | $45.6M |
| 5 | NYSE: PAR PAR TECHNOLOGY CORP | $22.94 +2.59% | 5.3% | 2.4M | $42.1M |
| 6 | NYSE: WEAV WEAVE COMMUNICATIONS INC | $7.40 +0.14% | 5.1% | 6.8M | $40.7M |
| 7 | NYSE: TFX TELEFLEX INCORPORATED | $165.85 +3.95% | 4.8% | 305K | $38.7M |
| 8 | NYSE: AIV APARTMENT INVT & MGMT CO | $1.40 −0.71% | 4.5% | 12.2M | $36.2M |
| 9 | NYSE: MAGN MAGNERA CORP | $11.91 −0.92% | 4.1% | 2.8M | $32.9M |
| 10 | NASDAQ: OCTV OCTAVE INTELLIGENCE PLC | — — | 3.9% | 1.9M | $31.3M |
| 11 | NASDAQ: XOMA XOMA ROYALTY CORPORATION | $40.17 0.00% | 3.8% | 709K | $30.1M |
| 12 | NYSE: RHLD RESOLUTE HLDGS MGMT INC | $147.78 +1.73% | 3.7% | 202K | $29.3M |
| 13 | NYSE: BV BRIGHTVIEW HLDGS INC | $8.81 +0.46% | 3.4% | 1.9M | $27.5M |
| 14 | NASDAQ: PPSI POWER SOLUTIONS INTL INC | $2.15 −0.46% | 2.9% | 601K | $23.4M |
| 15 | NASDAQ: CCOI COGENT COMM HOLDINGS INC | $3.18 +0.16% | 2.9% | 1.7M | $23.0M |
| 16 | NYSE: AD ARRAY DIGITAL INFRASTRUCTURE | $27.00 −0.81% | 2.7% | 597K | $21.7M |
| 17 | NYSE: CMP COMPASS MINERALS INTL INC | $20.51 −3.80% | 2.5% | 632K | $19.7M |
| 18 | NYSE: GDOT GREEN DOT CORP | $11.40 −1.81% | 2.0% | 1.2M | $16.3M |
| 19 | NYSE: SPB SPECTRUM BRANDS HOLDINGS INC | $82.04 +1.12% | 2.0% | 185K | $15.9M |
| 20 | NYSE: XRN CHIRON REAL ESTATE INC | — — | 1.9% | 406K | $15.2M |
| 21 | NASDAQ: RCKT ROCKET PHARMACEUTICALS INC | $2.11 0.00% | 1.7% | 4.0M | $13.7M |
| 22 | NASDAQ: FLWS 1 800 FLOWERS COM INC | $1.99 +2.84% | 1.5% | 3.5M | $12.2M |
| 23 | NASDAQ: NODK NI HLDGS INC | $14.90 +0.88% | 1.3% | 670K | $10.5M |
| 24 | NASDAQ: GRAL GRAIL INC | $102.10 −3.57% | 1.3% | 150K | $10.2M |
| 25 | NYSE: NVRI ENVIRI CORP | $23.77 −1.86% | 1.0% | 374K | $8.2M |
Showing 1–25 of 34 positions on this page reported in this 13F.
- Healthcare46%
- Industrials11%
- Consumer Cyclical7.2%
- Real Estate6.2%
- Consumer Defensive6.1%
- Communication Services5.6%
- Technology5.3%
- Financial Services3.3%
- Basic Materials2.5%
- AddedQDELQUIDELORTHO CORP+45.3%$116.0M
- AddedMAGNMAGNERA CORP+1.4%$32.9M
- NewOCTVOCTAVE INTELLIGENCE PLC—$31.3M
- NewXOMAXOMA ROYALTY CORPORATION—$30.1M
- NewPPSIPOWER SOLUTIONS INTL INC—$23.4M
- AddedCCOICOGENT COMM HOLDINGS INC+3.5%$23.0M
- AddedGDOTGREEN DOT CORP+744%$16.3M
- NewXRNCHIRON REAL ESTATE INC—$15.2M
- AddedRCKTROCKET PHARMACEUTICALS INC+26.3%$13.7M
- NewNVRIENVIRI CORP—$8.2M
- ReducedTBPHTHERAVANCE BIOPHARMA INC−29.1%$58.4M
- ReducedINDVINDIVIOR PHARMACEUTICALS INC−34.7%$53.6M
- ReducedCNNECANNAE HLDGS INC−3.0%$45.6M
- ReducedPARPAR TECHNOLOGY CORP−11.5%$42.1M
- ReducedWEAVWEAVE COMMUNICATIONS INC−3.0%$40.7M
- ReducedTFXTELEFLEX INCORPORATED−23.8%$38.7M
- ReducedRHLDRESOLUTE HLDGS MGMT INC−16.5%$29.3M
- ReducedBVBRIGHTVIEW HLDGS INC−7.6%$27.5M
- ReducedADARRAY DIGITAL INFRASTRUCTURE−63.1%$21.7M
- ReducedCMPCOMPASS MINERALS INTL INC−17.9%$19.7M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | ZOOZ ZOOZ Strategy Ltd. | 13G | 8.6% | 13.9M | Filed 17 FEB 2026 |
| 2 | TBPH Theravance Biopharma, Inc. | 13G | 8.5% | 4.3M | Filed 17 FEB 2026 |
| 3 | AIV APARTMENT INVESTMENT & MANAGEMENT CO | 13G | 8.1% · 2 classes | 11.6M | Filed 25 MAR 2026 |
| 4 | QDEL QuidelOrtho Corporation | 13G | 7.8% | 5.3M | Filed 16 NOV 2026 |
| 5 | MAGN Magnera Corporation | 13G | 7.7% · 2 classes | 2.8M | Filed 15 MAY 2026 |
| 6 | CNNE Cannae Holdings, Inc. | 13G | 7.6% · 2 classes | 3.5M | Filed 17 FEB 2026 |
| 7 | — City Office Reit, Inc. | 13G | 6.9% | 2.8M | Filed 17 FEB 2026 |
| 8 | NVRI Enviri Corp | 13G | 6.2% | 5.0M | Filed 17 FEB 2026 |
| 9 | SRG Seritage Growth Properties | 13G | 5.4% | 3.0M | Filed 16 NOV 2026 |
Showing all 9 disclosed stakes.
Reading Newtyn Management, LLC’s 13F portfolio
Newtyn Management, LLC’s $800.9M 13F book is spread across 34 reported positions and is highly concentrated — its ten largest positions alone are 62% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are QDEL, TBPH, INDV, CNNE and PAR, led by QUIDELORTHO CORP (QDEL) at 14% of the portfolio. The heaviest sector exposure is Healthcare (46%), then Industrials (11%).
What Newtyn Management, LLC changed last quarter
Between 2026-03-31 and Q2 2026, Newtyn Management, LLC was a net seller: it opened 8 new positions and added to 7 more, while trimming 13 and closing 7 outright. Against a 34-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was QUIDELORTHO CORP (QDEL), and its biggest reduction was THERAVANCE BIOPHARMA INC (TBPH).
What a 13F does and doesn’t reveal
A 13F captures only Newtyn Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Newtyn Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Newtyn Management, LLC's profile on this page is built directly from those filings.
How current is the 13F data on Newtyn Management, LLC's page?
It reflects Newtyn Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Newtyn Management, LLC files its next quarterly report, this page refreshes automatically.
Can I see Newtyn Management, LLC's complete list of holdings?
This page highlights Newtyn Management, LLC's largest positions rather than all 34 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Newtyn Management, LLC's filings.
Does a 13F show everything Newtyn Management, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Newtyn Management, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Newtyn Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

